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Human seminal plasma allergy is a rare phenomenon. Its clinical manifestations are diverse, and range from mild local pruritus 
to fatal anaphylaxis. Treatment varies with severity of the reactions: abstinence, condom usage or immunotherapy (subcutaneous 
or intravaginal) with seminal fluid. Local allergic reactions can be managed by prophylactic use of antihistamines or local cromolyn 
cream. A 33-year-old female visited the Asthma and Allergy Clinic in Seoul National University Bundang Hospital for the recurrent 
generalized urticarial reactions after sexual intercourse. She had been suffering from asthma, allergic rhinoconjunctivitis and atopic 
dermatitis for 10 years. She gave birth to a baby 6 months ago and no problem before. However, recently she began to recognize 
unexpected generalized urticaria that occurred after the sexual intercourse with husband. She wanted to have the second baby but 
hesitated because of the recurrent symptoms after the intercourse. She showed positive response to skin prick test with her husband’s 
seminal fluid. The IgE-binding components were 15, 22, 28, and 35 kDa. Considering her moderate cutaneous reactions, we decided 
to try prophylactic treatments with oral anti-histamine one hour before sexual intercourse. She did not experience urticarial reactions 
with intercourse while oral anti-histamine was administered in advance. Finally, treatment outcome was successful, and the couple 
successfully gave birth to their second baby. We suppose that prophylactic antihistamine may be also applied in seminal plasma 
allergy patients if systemic reactions are limited to mild to moderate generalized urticaria.
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INTRODUCTION
Allergy to human seminal fluid is an uncommon phenomenon. 
It is usually considered to be an IgE-mediated hypersensitivity 
reaction to proteins in the seminal fluid. The clinical manifestations 
range from local pruritus to fatal anaphylactic reactions. Treatment 
can vary with severity of the reactions. Here we report a case 
of human seminal fluid allergy presenting as urticaria in which 
pregnancy was successful after prophylactic anti-histamine 
treatments.
CASE REPORT
A 33-year-old female visited the Asthma and Allergy Clinic in 
Seoul National University Bundang Hospital for the recurrent 
generalized urticarial reactions after sexual intercourse with 
her husband. She had been suffering from asthma, allergic 
rhinoconjunctivitis and atopic dermatitis for 10 years. She was 
married 8 years ago, and gave birth to a baby 6 months ago. She 
had no problem with the intercourse before. However, recently 
she began to recognize unexpected symptoms that occurred 
after the sexual intercourse with husband. The manifestation was 
generalized urticaria with immediate onset. She wanted to have 
the second baby but hesitated because of the recurrent symptoms 
after the intercourse.
Inhalant allergen skin prick tests were positive to Dermatophagoides 
pteronyssinus, Dermatophagoides farinae, indoor molds, cat dander 
and dog dander. Seminal plasma from her husband was separated 
by centrifugation of semen at 5,000 rpm for 5 min at 4°C. Then 
skin prick test was performed using her husband’s undiluted 
seminal plasma, and it yielded a positive reaction with a wheal 
diameter of 5 × 5 mm to semen. The positive control (1 mg/mL 
histamine; Allergopharma, Germany) resulted in a 3 × 3 mm wheal 
reaction, and the negative control (0.9% saline) did not show skin 
responses. To identify specific IgE and their binding components, 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
immunoblotting was performed with seminal plasma from her 
husband and unrelated healthy controls. The immunoblotting 
revealed IgE-binding components of 15, 22, 28, and 35 kDa from 
her husband’s seminal fluid. Common IgE-binding components 
reacted with other seminal fluid were 22, 28, and 35 kD (Fig. 
1). Based on medical history and test results, the patient was 
diagnosed with hypersensitivity to seminal plasma. As the couple 
wanted to conceive another baby, various treatment options were 
discussed. Considering her moderate cutaneous reactions, we 
decided to try prophylactic treatments with oral anti-histamines 
(loratadine 10 mg once daily, Clarityne®; Schering-Plough, USA) 
one hour before sexual intercourse. She did not experience 
urticarial reactions with intercourse while oral anti-histamine 
was administered in advance. Finally, treatment outcome was 
successful, and the couple successfully gave birth to their second 
baby. After the birth, they did not want further conception. They 
were recommended to use condom protection and had no 
problem.
DISCUSSION
Human seminal plasma allergy is a rare disorder. In the literature, 
only more than 80 cases have been reported since the first 
English case report in 1967 by Halpern et al. [1]. Information on its 
prevalence is not available, but results from a questionnaire survey 
suggested that this hypersensitivity might be more common than 
previously recognized or reported [2]. 
The age of onset is usually between 20 and 30 years old. In a 
comprehensive review by Shah et al. [3], 61% of reported cases 
were in the third decade of life. Women over than 40 years old are 
less commonly affected. The clinical manifestations are diverse, but 
the reactions can be simply classified as local, systemic or both. 
Frequency of manifestations is one-third for each type of reaction. 
The local symptoms are commonly vulvar and vaginal itching, 
burning, pain, swelling, and erythema. The systemic reactions 
include generalized itching, urticaria, angioedema, respiratory 
distress, rhinitis symptoms, or fatal anaphylactic shock. A case of 
fixed eruption has been also described [4]. The time of onset is 
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Fig. 1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and 
immunoblotting assay of seminal plasma from the patient’s husband and 
unrelated healthy controls. Husb: husband, C:  controls.apallergy.org
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mostly within 1 h, and only 13% developed between 1 and 15 h 
[3]. Thus, most of human seminal plasma hypersensitivity reactions 
are considered as classical IgE-mediated reactions. Although rare, 
cases also have been described for type III or IV hypersensitivity 
reactions [4, 5]. Symptoms resolve spontaneously in more than 
half of the cases, but severe reactions often required emergency 
interventions [3]. Atopic background may be associated with 
increased risk of human seminal plasma allergy [3]. 
Interestingly, 40% of seminal plasma allergy patients experienced 
hypersensitivity reactions on their first sexual intercourse [6]. Thus, 
the possibility has been raised that sensitization to an unknown 
allergen may cross-react with allergens in human seminal fluid. In 
this regard, a recent work by Basagaña et al. [7] was outstanding as 
they suggested that sensitization to dog epithelium may be a risk 
factor for human seminal plasma allergy. They demonstrated IgE 
cross-reactivity between dog allergen and the prostate-specific 
antigen. Another remarkable work by Mattsson et al. [8] identified 
that prostatic kallikrein is a major dog allergen, and that it is a key 
culprit in cross-sensitization and IgE-mediated seminal fluid allergy. 
Interestingly, our case was also sensitized to dog epithelium 
and had a history of dog breeding, but she developed urticarial 
reactions after a gap of time since first intercourse. It is unclear 
whether cross-sensitization existed between dog epithelium and 
seminal fluid allergens in this patient. 
The diagnosis is based on careful history taking. Condom test 
can be diagnostic by demonstrating that symptoms of seminal 
fluid allergy can be abolished with condom usage [9]. Possible 
sensitizations to other antigens (latex, lubricants, or contraceptives) 
also should be evaluated [10]. Differential diagnosis includes 
contact dermatitis, candida or bacterial vulvovaginitis, coitus-linked 
asthma, ‘honeymoon rhinitis’, anxiety, irritant reactions or latex 
allergy [3, 10, 11]. However, in vivo skin tests are the most important 
for the diagnosis. Among 71 patients reviewed by Shah et al. 
[3], 93% of skin tested patients showed positive responses. For 
skin testing, the first step is to obtain a fresh ejaculate from their 
husbands or sexual partners. The sample needs to be liquefied 
at room temperature for 30 min, and then centrifugation is to be 
carried out to separate spermatozoa and seminal plasma [11]. Most 
reactions are known to develop with seminal plasma fractions 
[10]. In vitro measurements for specific IgE antibody include 
radioallergosorbent tests and enzyme-linked immunosorbent 
assays [6, 12]. Commercial kits for specific IgE tests are available, 
but their clinical utility is still uncertain [11]. Identification of 
allergens can be performed by electrophoresis, chromatographic 
separation and IgE immunoblotting assays [9, 10, 13, 14]. It has 
been suggested that 14~75 kDa proteins of seminal fluid could be 
the IgE binding components [15, 16]. We have previously reported 
a middle aged woman with severe seminal fluid allergy. In that 
case, the common IgE-binding components were 15, 28, 35, 45, 
90 kDa and the specific IgE-binding components to her husband’s 
seminal fluid were 13, 26, and 30 kDa [14]. Regarding present case, 
28, and 35 kDa could be the common IgE-binding components.
For treatment, avoidance is the mainstay. Exposure can be 
prevented by abstinence or condom usage. Improvements in 
clinical and skin test responses have been reported after the 
condom usages for 6 to 12 months [17]. However, in cases 
hoping for pregnancy, desensitization can be considered as a 
useful treatment option. Various immunotherapy protocols have 
been tried since the first report in 1967 by Halpern et al. [1]. Rush 
immunotherapy protocols have been also performed successfully 
by subcutaneous or intravaginal route [18, 19]. Following 
desensitization, a regular schedule of sexual intercourse or 
exposure to human seminal plasma needs to be maintained every 
2-3 days to continue tolerance status [11]. In patients with local 
reactions, allergic symptoms can be managed by prophylactic 
usage of antihistamines or local cromolyn cream. However, 
to our knowledge, no cases have been reported for a patient 
with systemic reactions that achieved successful pregnancy 
only with prophylactic antihistamine treatments. We suppose 
that prophylactic antihistamine may be also applied in seminal 
plasma allergy patients if systemic reactions are limited to mild to 
moderate generalized urticaria. 
In summary, we report a case of human seminal plasma allergy 
in which pregnancy was successful. The diagnosis was based on 
clinical history and skin tests. Mild to moderate urticarial cases may 
be prophylactically managed with oral anti-histamines to achieve 
pregnancy. 
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